The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• NowsheenSAzizKPanayiotidisMIGeorgakilasAGMolecular markers for cancer prognosis and treatment: have we struck gold?Cancer Lett20123271–214215222120674
   PubMed Web of Science ®Google Scholar
• HayesJPeruzziPPLawlerSMicroRNAs in cancer: biomarkers, functions and therapyTrends Mol Med201420846046925027972
   PubMed Web of Science ®Google Scholar
• HeLHannonGJMicroRNAs: small RNAs with a big role in gene regulationNat Rev Genet20045752253115211354
   PubMed Web of Science ®Google Scholar
• FangWFanYFaZMicroRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanomaOncotarget201788132531326328129648
   PubMedGoogle Scholar
• GuWZhanHZhouXYMicroRNA-22 regulates inflammation and angiogenesis via targeting VE-cadherinFEBS Lett2017591351352628112401
   PubMedGoogle Scholar
• DongSYinHDongCPredictive value of plasma microRNA-216a/b in the diagnosis of esophageal squamous cell carcinomaDis Markers20162016185706726989293
   PubMedGoogle Scholar
• MaYJHaCFBaiZMLiHNXiongYJiangJOverexpression of microRNA-205 predicts lymph node metastasis and indicates an unfavorable prognosis in endometrial cancerOncol Lett20161264403441028105153
   PubMedGoogle Scholar
• TangXRWenXHeQMMicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinomaCell Death Dis201781e256628102841
   PubMedGoogle Scholar
• LeiYLiBTongSmiR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cellsPLoS One2015102e011780925658842
   PubMedGoogle Scholar
• YeZYinSSuZDownregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2Oncotarget2016725375243753527229528
   PubMedGoogle Scholar
• LuoLZhangTLiuHMiR-101 and Mcl-1 in non-small cell lung cancer: expression profile and clinical significanceMed Oncol20122931681168621993632
   PubMedGoogle Scholar
• BaoRFShuYJHuYPmiR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinomaOncotarget2016716223392235426968949
   PubMedGoogle Scholar
• LiJTJiaLTLiuNNMiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7Oncotarget2015631308183083026360780
   PubMedGoogle Scholar
• TianTMingyiMQiuXQiuYMicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastomaOncotarget2016748795847959527792996
   PubMedGoogle Scholar
• LiXPYuanZBLiuWJCPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in gliomaCell Death Dis20134e67523788032
   PubMedGoogle Scholar
• ZhangHQiFCaoYChenMZuXDown-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosisMed Sci Monit20142081281724834983
   PubMedGoogle Scholar
• LiMTianLRenHMicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8J Transl Med20151327126286725
   PubMedGoogle Scholar
• ZhengFLiaoYJCaiMYSystemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsPLoS Genet2015112e100487325693145
   PubMed Web of Science ®Google Scholar
• ZhangYGuoXXiongLMicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinomaFEBS Lett2012586244362437023178713
   PubMed Web of Science ®Google Scholar
• SlatteryMLHerrickJSPellattDFSite-specific associations between miRNA expression and survival in colorectal cancer casesOncotarget2016737601936020527517623
   PubMedGoogle Scholar
• LvXLiJYangBClinical effects of miR-101 on prognosis of hepa-tocellular carcinoma and carcinogenic mechanism of anti-miR-101Oncol Rep20163642184219227498785
   PubMedGoogle Scholar
• MoherDLiberatiATetzlaffJAltmanDGPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ2009339b253519622551
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
   PubMed Web of Science ®Google Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• EggerMSmithGDSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• InamuraKMajor tumor suppressor and oncogenic non-coding RNAs: clinical relevance in lung cancerCells2017626020012
   Google Scholar
• Nana-SinkamSPCroceCMMicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical useGenome Biol201415944525315999
   PubMed Web of Science ®Google Scholar
• InamuraKIshikawaYMicroRNA in lung cancer: novel biomarkers and potential tools for treatmentJ Clin Med2016535030036
   Google Scholar
• NgLWanTMManJHIdentification of serum miR-139-3p as a non-invasive biomarker for colorectal cancerOncotarget2017816273932740028404964
   PubMedGoogle Scholar
• GaoFZhaoZLZhaoWTmiR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cellsBiochem Biophys Res Commun2013431361061623291181
   PubMedGoogle Scholar
• ZhengQChenCGuanHKangWYuCPrognostic role of microRNAs in human gastrointestinal cancer: a systematic review and meta-analysisOncotarget Epub2017329
   Google Scholar
• ZhaoHTangHHuangQMiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinomaAm J Cancer Res20166112575258627904772
   PubMedGoogle Scholar
• WuBLeiDWangLMiRNA-101 inhibits oral squamous-cell carcinoma growth and metastasis by targeting zinc finger E-box binding homeobox 1Am J Cancer Res2016661396140727429852
   PubMedGoogle Scholar
• VaramballySCaoQManiRSGenomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancerScience200832259081695169919008416
   PubMed Web of Science ®Google Scholar
• ZhangJGGuoJFLiuDLLiuQWangJJMicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of Zeste homolog 2J Thorac Oncol20116467167821270667
   PubMed Web of Science ®Google Scholar
• JiangRZhangCLiuGGuRWuHMicroRNA-101 inhibits proliferation, migration and invasion in osteosarcoma cells by targeting ROCK1Am J Cancer Res201771889728123850
   PubMed Web of Science ®Google Scholar
• HuiYLiYJingYFengJQDingYmiRNA-101 acts as a tumor suppressor in oral squamous cell carcinoma by targeting CX chemokine receptor 7Am J Transl Res20168114902491127904690
   PubMed Web of Science ®Google Scholar
• KonnoYDongPXiongYMicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cellsOncotarget20145156049606225153722
   PubMedGoogle Scholar
• LinXGuanHLiHmiR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinomaBiomed Rep20142112212624649082
   PubMedGoogle Scholar
• LiuLGuoJYuLmiR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancerTumour Biol20143512126191262625260883
   PubMed Web of Science ®Google Scholar
• SunQLiuTZhangTMiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1Mol Med Rep20151153330333625607713
   PubMed Web of Science ®Google Scholar